Pharmacokinetics of Orally Administered Oseltamivir in Healthy Obese and Nonobese Thai Subjects

Oseltamivir is the most widely used anti-influenza drug. In the 2009 H1N1 pandemic, in which the influenza viruses were oseltamivir sensitive, obesity was identified as a risk factor for severe disease and unfavorable outcomes. The aim of this study was to investigate the pharmacokinetic properties...

Descripción completa

Detalles Bibliográficos
Autores principales: Jittamala, Podjanee, Pukrittayakamee, Sasithon, Tarning, Joel, Lindegardh, Niklas, Hanpithakpong, Warunee, Taylor, Walter Robert John, Lawpoolsri, Saranath, Charunwattana, Prakaykaew, Panapipat, Salwaluk, White, Nicholas J., Day, Nicholas P. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2014
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957867/
https://www.ncbi.nlm.nih.gov/pubmed/24366750
http://dx.doi.org/10.1128/AAC.01786-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957867/
https://www.ncbi.nlm.nih.gov/pubmed/24366750
http://dx.doi.org/10.1128/AAC.01786-13

Ejemplares similares